Xiaoyan Ma

2.4k total citations
74 papers, 1.3k citations indexed

About

Xiaoyan Ma is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Xiaoyan Ma has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Nephrology and 13 papers in Surgery. Recurrent topics in Xiaoyan Ma's work include Dialysis and Renal Disease Management (10 papers), Cancer-related molecular mechanisms research (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Xiaoyan Ma is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Cancer-related molecular mechanisms research (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Xiaoyan Ma collaborates with scholars based in China, United States and Germany. Xiaoyan Ma's co-authors include Yingfeng Shi, Na Liu, Shougang Zhuang, Andong Qiu, Yan Hu, Min Tao, Hui Chen, Jinqing Li, Lili Wei and Xu‐Qing Wang and has published in prestigious journals such as Nucleic Acids Research, Blood and Cell Metabolism.

In The Last Decade

Xiaoyan Ma

71 papers receiving 1.3k citations

Peers

Xiaoyan Ma
Xiaoyan Ma
Citations per year, relative to Xiaoyan Ma Xiaoyan Ma (= 1×) peers Simona Simone

Countries citing papers authored by Xiaoyan Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Ma more than expected).

Fields of papers citing papers by Xiaoyan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Ma. The network helps show where Xiaoyan Ma may publish in the future.

Co-authorship network of co-authors of Xiaoyan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Ma. A scholar is included among the top collaborators of Xiaoyan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Ma. Xiaoyan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yingfeng, Jinqing Li, Hui Chen, et al.. (2025). Inhibition of Caspase‐1 Suppresses GSDMD‐mediated Peritoneal Mesothelial Cell Pyroptosis and Inflammation in Peritoneal Fibrosis. Small. 21(14). e2409362–e2409362. 2 indexed citations
2.
Lin, Chen, et al.. (2024). Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer. Cancer Cell International. 24(1). 352–352. 1 indexed citations
4.
Xu, Xiaoming, Zhiwen Fan, Xiaoyan Ma, et al.. (2024). Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease. Liver International. 44(3). 865–875. 3 indexed citations
5.
Ma, Xiaoyan, et al.. (2024). Synergistic effects of bloom helicase (BLM) inhibitor AO/854 with cisplatin in prostate cancer. Scientific Reports. 14(1). 24962–24962. 1 indexed citations
6.
Zhang, Yaqi, Tong Guo, Kai Wang, et al.. (2023). Effects of BAMBI on luteinized follicular granulosa cell proliferation and steroid hormone production in sheep. Molecular Reproduction and Development. 90(3). 153–165. 5 indexed citations
7.
Liu, Chuan, Xiaoming Xu, Xiaoyan Ma, et al.. (2023). Association of Diabetes Mellitus with All-Cause and Cause-Specific Mortality among Patients with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Longitudinal Cohort Study. Journal of Personalized Medicine. 13(3). 554–554. 1 indexed citations
8.
Chen, Hui, Yingfeng Shi, Jinqing Li, et al.. (2023). Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization. Frontiers in Immunology. 14. 1137332–1137332. 20 indexed citations
9.
Shi, Yingfeng, Min Tao, Hui Chen, et al.. (2022). Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney International. 103(3). 544–564. 37 indexed citations
10.
Hu, Yan, Yingfeng Shi, Hui Chen, et al.. (2022). Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. Frontiers in Immunology. 13. 858494–858494. 72 indexed citations
11.
Tao, Min, Xiaoyan Ma, Yingfeng Shi, et al.. (2021). Prevalence and related factors of hyperuricaemia in Shanghai adult women of different ages: a multicentre and cross-sectional study. BMJ Open. 11(9). e048405–e048405. 4 indexed citations
12.
Zhou, Xun, Hui Chen, Yingfeng Shi, et al.. (2021). The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury. Frontiers in Pharmacology. 12. 695237–695237. 13 indexed citations
13.
Shi, Yingfeng, Yan Hu, Yi Wang, et al.. (2021). Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Frontiers in Pharmacology. 12. 724141–724141. 22 indexed citations
14.
Ma, Xiaoyan, Yingfeng Shi, Min Tao, et al.. (2020). Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study. BMJ Open. 10(2). e029949–e029949. 26 indexed citations
16.
Ma, Xiaoyan, Dawei Wang, Xiangjun Li, et al.. (2019). Systematic analysis of long non-coding RNA and mRNA expression changes in ApoE-deficient mice during atherosclerosis. Molecular and Cellular Biochemistry. 462(1-2). 61–73. 4 indexed citations
17.
Zhu, Hui, Xiaoyan Ma, & Jinming Yu. (2017). PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S1484–S1484. 1 indexed citations
18.
Gao, Yufang, et al.. (2015). The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients. Therapeutics and Clinical Risk Management. 11. 863–863. 35 indexed citations
19.
Fan, Xin, Zhengfa Mao, Xiaoyan Ma, et al.. (2015). Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine. Tumor Biology. 37(2). 2267–2273. 6 indexed citations
20.
Wang, Xu‐Qing, Yuezhen Deng, Zhengfa Mao, et al.. (2012). CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer. Tumor Biology. 33(5). 1745–1758. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026